Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Stock-based compensation

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Apr 30, 202410-11.36%
Apr 30, 202311+48.75%
Apr 30, 20227+91.49%
Apr 30, 20214+54.22%
Apr 30, 20202+56.68%
Apr 30, 20192+3.71%
Apr 30, 20182-54.27%
Apr 30, 20173-31.34%
Apr 30, 20165-26.92%
Apr 30, 20157+7.97%
Apr 30, 20146+80.70%
Apr 30, 20133+24.05%
Apr 30, 20123

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat